Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol
Objectives:. To report the prevalence of, and evaluate risk factors for, the development of hypertriglyceridemia (defined as a serum triglyceride level of > 400 mg/dL) in patients with coronavirus disease 2019 who received propofol. Design:. Single-center, retrospective, observational analysis. S...
| Published in: | Critical Care Explorations |
|---|---|
| Main Authors: | Mary P. Kovacevic, PharmD, BCCCP, BCPS, Kevin M. Dube, PharmD, BCCCP, BCPS, Kenneth E. Lupi, PharmD, BCCCP, BCPS, Paul M. Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS, Jeremy R. DeGrado, PharmD, BCCCP, BCPS |
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer
2021-01-01
|
| Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000330 |
Similar Items
A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01)
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01)
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01)
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01)
Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01)
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01)
Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01)
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01)
Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)
Evaluating the impact of an emergency department protocol that guides management of methamphetamine-induced agitation and psychosis
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)
by: Julie Nguyen, PharmD, et al.
Published: (2022-01-01)
FARMACÉUTICOS CLÍNICOS: PROFESIONALES ESENCIALES DEL EQUIPO DE ATENCIÓN CLÍNICA
by: Judith Jacobi, PharmD, ACCP, MCCM, BCPS, BCCCP
Published: (2016-09-01)
by: Judith Jacobi, PharmD, ACCP, MCCM, BCPS, BCCCP
Published: (2016-09-01)
Serotonin syndrome and neuroleptic malignant syndrome: A case report of intersecting symptomatology
by: Loulwa Maktabi, PharmD, BCPS, et al.
Published: (2024-02-01)
by: Loulwa Maktabi, PharmD, BCPS, et al.
Published: (2024-02-01)
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review
and Meta-Analysis
by: Awatif Hafiz PharmD, BCCP, et al.
Published: (2023-08-01)
by: Awatif Hafiz PharmD, BCCP, et al.
Published: (2023-08-01)
Sotatercept for Pulmonary Arterial Hypertension in the Inpatient Setting
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024-02-01)
by: Heather Torbic PharmD, FCCM, BCPS, BCCCP, et al.
Published: (2024-02-01)
Clinical outcomes for patients on antiplatelet and anticoagulants in thoracoabdominal trauma
by: Victoria Sharp, DO, FACS, FACOS, et al.
Published: (2023-12-01)
by: Victoria Sharp, DO, FACS, FACOS, et al.
Published: (2023-12-01)
Evaluation of Hydrocortisone Discontinuation Strategies in Septic Shock: A Retrospective Cohort Study
by: Hanine O. AlMubayedh, PharmD, BCPS, BCCCP, et al.
Published: (2025-07-01)
by: Hanine O. AlMubayedh, PharmD, BCPS, BCCCP, et al.
Published: (2025-07-01)
Formulary Reconciliation: Implementation of a Comprehensive Approach to Formulary Maintenance and Standardization
by: Janine G. Martino PharmD, BCOP, APh, et al.
Published: (2024-08-01)
by: Janine G. Martino PharmD, BCOP, APh, et al.
Published: (2024-08-01)
Ketamine for Primary Analgosedation in Critically Ill Surgery and Trauma Patients Requiring Mechanical Ventilation
by: Bradley J. Peters, PharmD, BCPS, BCCCP, et al.
Published: (2024-02-01)
by: Bradley J. Peters, PharmD, BCPS, BCCCP, et al.
Published: (2024-02-01)
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021-07-01)
by: Payal H. Desai, PharmD, BCCCP, et al.
Published: (2021-07-01)
Characterizing Critical Care Pharmacy Services Across the United States
by: Robert MacLaren, PharmD, MPH, FCCM, FCCP, et al.
Published: (2021-01-01)
by: Robert MacLaren, PharmD, MPH, FCCM, FCCP, et al.
Published: (2021-01-01)
A retrospective review of intramuscular olanzapine and parenteral benzodiazepine coadministration in the emergency department
by: Jessica Laub, PharmD, BCEMP, et al.
Published: (2024-08-01)
by: Jessica Laub, PharmD, BCEMP, et al.
Published: (2024-08-01)
Offering a combined resident research training program and pharmacy student elective may help improve resident publication rates
by: Brown Geoffrey PharmD, et al.
Published: (2023-08-01)
by: Brown Geoffrey PharmD, et al.
Published: (2023-08-01)
Enteral Administration of Twice-Daily Dolutegravir and Rilpivirine as a Part of a Triple-Therapy Regimen in a Critically Ill Patient with HIV
by: Sarah Lynn Turley PharmD, BCPS, et al.
Published: (2017-03-01)
by: Sarah Lynn Turley PharmD, BCPS, et al.
Published: (2017-03-01)
Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)
by: Tressa McMorris, PharmD, BCPS, et al.
Published: (2021-07-01)
Evaluation of Rivaroxaban Exposure via
Anti-Xa Levels During VTE Prophylaxis
in Hospitalized Patients
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)
Evaluation of drug-drug interactions in hospitalized patients on medications for OUD
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01)
by: Olivia Berger, PharmD, et al.
Published: (2021-07-01)
Impact of marketing to improve patient access to care and clinic utilization for clinical pharmacy specialists
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)
by: Nora Bairagdar, PharmD, BCPS, et al.
Published: (2023-03-01)
Venous Thromboembolism Prophylaxis with Enoxaparin Versus Unfractionated Heparin in Patients with Low Body Weight
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)
by: David Michael Kaylor PharmD, et al.
Published: (2023-02-01)
Record Setting Temperatures in the Setting of SARS-CoV-2 Suggests Dexmedetomidine Drug-Induced Fever: A Case Report
by: Megan Meier PharmD, BCPS, et al.
Published: (2024-06-01)
by: Megan Meier PharmD, BCPS, et al.
Published: (2024-06-01)
Pharmacist impact on medication reconciliation of behavioral health patients boarding in the emergency department
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)
by: Mary Accomando, PharmD, BCPP, et al.
Published: (2022-06-01)
Comparison of droperidol and haloperidol for acute agitation in the emergency department: A retrospective cohort study
by: Francesca DiGuglielmo, PharmD, et al.
Published: (2025-10-01)
by: Francesca DiGuglielmo, PharmD, et al.
Published: (2025-10-01)
Development and implementation of a physician-pharmacist collaborative practice model for provision and management of buprenorphine/naloxone
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)
by: Lindsay M. Mailloux, PharmD, et al.
Published: (2021-01-01)
Differentiating probable nitrofurantoin-induced drug fever from antipsychotic-induced hyperthermia in a patient receiving clozapine
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01)
by: Stephen B. Vickery, PharmD, BCPS, et al.
Published: (2022-06-01)
Procalcitonin-Guided Management and Duration of Antibiotic Therapy in Critically Ill Cancer Patients With Sepsis (Pro-Can Study): A Randomized Controlled Trial
by: Lama H. Nazer, PharmD, BCPS, FCCM, et al.
Published: (2024-10-01)
by: Lama H. Nazer, PharmD, BCPS, FCCM, et al.
Published: (2024-10-01)
Knowledge and attitude of Lebanese women about cosmetics: a cross-sectional survey
by: Bahia Chahine, RPh, PharmD, MSc, BCPS, et al.
Published: (2023-10-01)
by: Bahia Chahine, RPh, PharmD, MSc, BCPS, et al.
Published: (2023-10-01)
Management of Hypertriglyceridemia-Induced Acute Pancreatitis in a Nondiabetic Patient
by: Jamie M. Reed, PharmD, BCPS, et al.
Published: (2021-02-01)
by: Jamie M. Reed, PharmD, BCPS, et al.
Published: (2021-02-01)
Evaluation of the use of chlorpromazine for agitation in pediatric patients
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)
by: Rajwoana Ahmed, PharmD, et al.
Published: (2023-03-01)
Derivation and Validation of a New Equation for Estimating Free Valproate Concentration in Critically Ill Adult Patients
by: Ji Tong Liu, PharmD, BCCCP, et al.
Published: (2023-10-01)
by: Ji Tong Liu, PharmD, BCCCP, et al.
Published: (2023-10-01)
Effectiveness of a clinical decision-support tool on adherence to prescribing and practice guidelines of high-risk antidepressant medications in geriatric patients
by: Madeline A. VanDaele, PharmD, et al.
Published: (2021-05-01)
by: Madeline A. VanDaele, PharmD, et al.
Published: (2021-05-01)
Survey of noncontrolled medication misuse patterns
by: Amelia Slane, PharmD, et al.
Published: (2022-06-01)
by: Amelia Slane, PharmD, et al.
Published: (2022-06-01)
Impact of Board Certified Psychiatric Pharmacists on improving urinary tract infection antibiotic appropriateness at an acute psychiatric hospital
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)
by: Hamad Mohammad Adam PharmD, BCPS, et al.
Published: (2023-10-01)
128 Evaluation of Heparin-Induced Thrombocytopenia Testing to Improve Anticoagulation Stewardship in an Acute Care Setting
by: Yelena Samofalova, PharmD, et al.
Published: (2025-05-01)
by: Yelena Samofalova, PharmD, et al.
Published: (2025-05-01)
Assessment of Anticoagulant Initiation in Patients With New-Onset Atrial Fibrillation During Emergency Department Visit
by: Ehsan Habeeb PharmD, BCPS, et al.
Published: (2023-05-01)
by: Ehsan Habeeb PharmD, BCPS, et al.
Published: (2023-05-01)
Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit
by: Sarah Gamcsik, PharmD, et al.
Published: (2024-08-01)
by: Sarah Gamcsik, PharmD, et al.
Published: (2024-08-01)
Similar Items
-
A Retrospective, Single-Center Assessment of Changes in Pain, Agitation, and Delirium Management Before and During the COVID-19 Pandemic
by: Rachel L. Winner, PharmD, BCCCP, et al.
Published: (2025-01-01) -
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01) -
Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01) -
Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01) -
Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)
